Search research articles
Contact Us
Filters
Showing results (21-30 of 66) with videos related to
Page
of 7
Sort By:
Medical and Pediatric Oncology
|
January 1, 1976
Acute leukemia in Burkitt lymphoma
R L Heideman, J M Falletta, P Steuber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1994
Clinical pharmacodynamics of continuous infusion topotecan in children: systemic exposure predicts hematologic toxicity
C F Stewart, S D Baker, R L Heideman, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Cerebrospinal fluid pharmacokinetics and penetration of continuous infusion topotecan in children with central nervous system tumors
S D Baker, R L Heideman, W R Crom, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Carboplatin pharmacokinetics in young children with brain tumors
M E Tonda, R L Heideman, W P Petros, et al.
Pediatric Neurosurgery
|
January 1, 1994
Quality of survival among children treated for brain stem glioma
R K Mulhern, R L Heideman, Z A Khatib, et al.
Cancer
|
August 15, 1996
DNA index of glial tumors in children. Correlation with tumor grade and prognosis
P Mathew, T Look, X Luo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Phenytoin alters the disposition of topotecan and N-desmethyl topotecan in a patient with medulloblastoma
W C Zamboni, A J Gajjar, R L Heideman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 30, 1999
Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital
A W Walter, R K Mulhern, A Gajjar, et al.
Blood
|
December 1, 1982
Acute leukemia associated with the t(4;11) chromosome rearrangement: ultrastructural and immunologic characteristics
J L Parkin, D C Arthur, C S Abramson, et al.
Cancer
|
June 1, 1995
A phase II evaluation of thiotepa followed by other multiagent chemotherapy regimens in infants and young children with malignant brain tumors
B I Razzouk, R L Heideman, H S Friedman, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 66) with videos related to
Sort By:
Page
of 7
Medical and Pediatric Oncology
|
January 1, 1976
Acute leukemia in Burkitt lymphoma
R L Heideman, J M Falletta, P Steuber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1994
Clinical pharmacodynamics of continuous infusion topotecan in children: systemic exposure predicts hematologic toxicity
C F Stewart, S D Baker, R L Heideman, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Cerebrospinal fluid pharmacokinetics and penetration of continuous infusion topotecan in children with central nervous system tumors
S D Baker, R L Heideman, W R Crom, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Carboplatin pharmacokinetics in young children with brain tumors
M E Tonda, R L Heideman, W P Petros, et al.
Pediatric Neurosurgery
|
January 1, 1994
Quality of survival among children treated for brain stem glioma
R K Mulhern, R L Heideman, Z A Khatib, et al.
Cancer
|
August 15, 1996
DNA index of glial tumors in children. Correlation with tumor grade and prognosis
P Mathew, T Look, X Luo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Phenytoin alters the disposition of topotecan and N-desmethyl topotecan in a patient with medulloblastoma
W C Zamboni, A J Gajjar, R L Heideman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 30, 1999
Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital
A W Walter, R K Mulhern, A Gajjar, et al.
Blood
|
December 1, 1982
Acute leukemia associated with the t(4;11) chromosome rearrangement: ultrastructural and immunologic characteristics
J L Parkin, D C Arthur, C S Abramson, et al.
Cancer
|
June 1, 1995
A phase II evaluation of thiotepa followed by other multiagent chemotherapy regimens in infants and young children with malignant brain tumors
B I Razzouk, R L Heideman, H S Friedman, et al.
Page
of 7